515162-20-6

Basic information

• Product Name: [4-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL]METHYLAMINE
• Synonyms: AKOS BB-8921;[4-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL]METHYLAMINE;4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-BENZYLAMINE;1-(4-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL)METHANAMINE;4-[(4-Methylpiperazin-1-yl)methyl]benzylamine 97%;4-[(4-Methyl-1-piperazinyl)methyl]benzylamine;{4-[(4-Methylpiperazin-1-yl)methyl]phenyl}methylamine 97%;4-[(4-Methylpiperazin-1-yl)methyl]benzylamine, 1-[4-(Aminomethyl)benzyl]-4-methylpiperazine
• CAS NO: 515162-20-6
• Molecular Formula: C₁₃H₂₁N₃
• Molecular Weight: 219.33
• Product Categories: API intermediates;Building Blocks;Heterocyclic Building Blocks;Piperazines;Building Blocks;C13;Chemical Synthesis;Heterocyclic Building Blocks
• Mol File: 515162-20-6.mol

Chemical Properties

• Boiling Point: 336.5 °C at 760 mmHg
• Flash Point: 110 °C
• Appearance: /
• Density: 1.0154 g/mL at 25 °C
• Vapor Pressure: 0.000112mmHg at 25°C
• Refractive Index: n20/D 1.547
• CAS DataBase Reference: [4-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL]METHYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: [4-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL]METHYLAMINE(515162-20-6)
• EPA Substance Registry System: [4-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL]METHYLAMINE(515162-20-6)

Safety Data

• Hazard Codes: C,Xi
• Statements: 37/38-41
• Safety Statements: 26-39
• WGK Germany: 3
• Hazardous Substances Data: 515162-20-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
[4-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL]METHYLAMINE is used as a potential drug candidate for various therapeutic applications due to its structural features that may confer central nervous system depressant, analgesic, or anti-inflammatory properties.
Used in Research and Development:
In the field of medicinal chemistry, [4-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL]METHYLAMINE serves as a subject for further research and testing to explore its full range of biochemical and pharmacological properties, with the aim of identifying its specific mechanisms of action and potential therapeutic uses.

InChI:InChI=1/C13H21N3/c1-15-6-8-16(9-7-15)11-13-4-2-12(10-14)3-5-13/h2-5H,6-11,14H2,1H3

Upstream product

• 125743-63-7 4-[(4-methyl-1-piperazinyl)methyl]benzonitrile 
• 109-01-3 1-methyl-piperazine 
• 17201-43-3 4-cyanobenzyl bromide 

Relevant articles and documents

Cyano-pyrrolo-heteroaryl derivative, preparation method thereof and application of derivative to medicine

The invention relates to a cyano-pyrrolo-heteroaryl derivative, a preparation method thereof and an application of the derivative to medicine, and particularly relates to a novel cyano-pyrrolo-heteroaryl derivative as shown in a general formula (I), a pre

Structural-based design, synthesis, and antitumor activity of novel alloxazine analogues with potential selective kinase inhibition

Protein kinases are promising therapeutic targets for cancer therapy. Here, we applied multiple approaches to optimize the potency and selectivity of our reported alloxazine scaffold. Flexible moieties at position 2 of the hetero-tricyclic system were inc

SUBSTITUTED SULFONAMIDE COMPOUNDS

Substituted sulfonamide derivatives, a process for their preparation, pharmaceutical compositions containing these compounds, and to the use of substituted sulfonamide derivatives in the treatment or inhibition of pain and/or various disorders or disease states.